Best Australian Shares to Buy for Long-Term in Volatile Markets
Volatile markets act like a dual edged sword. While they succeed in shaking the weak kneed, suave investors hound such an opportunity to acquire quality stocks at a discount. The bargain for such stocks, that deserve a place in buy and hold forever category, is often short lived.
The rattled markets throw many such stocks out of favour temporarily which offer seasoned players a chance to build long term wealth creating portfolio.
Some top Australian shares to consider for long-term investment are
has delivered a strong performance for the financial year that ended on June 2025. The company reported its net income to rise by an impressive 37% to $1.401 billion from $1.021 billion in the previous financial year. This was on the back of a 10% increase in revenue which reached $5.146 billion compared to $4.685 billion in fiscal 2024. EBITDA and operating income also showed improvements that were supported by growth in both their Sleep and Breathing Health segment and Residential Care Software segment with revenue growth of 10% in both areas. Key drivers included increased device and mask sales, operational efficiencies and the integration of recent acquisitions like VirtuOx. The firm maintained a strong margin profile with a gross margin of 59.4%, improved from 56.7%. Customer growth and geographic diversification remain significant with sales distributed globally but with a focus on the United States, Europe, Asia and Latin America.
Pro Medicus Limited (ASX: PME)
has reported a strong Financial Year 2025 with revenue of $213.0 million which was up 31.9%. The company also reported underlying profit before tax to increase by 40.0% to $163.3 million. Net profit rose 39.2% to $115.2 million with cash and financial assets growing to $210.7 million. The company remains debt free and declared a fully franked final dividend of 30 cents per share. Strong contract wins totaling over $520 million including major deals with US healthcare providers such as Trinity Health, Duly Health and University of Kentucky underpin future growth.
delivered a strong Financial Year 2025 with revenue growing 23% to NZ$2.103 billion. Adjusted EBITDA also increased 22% to NZ$641 million. The company achieved a Rule of 40 outcome of 44.3% demonstrating balanced growth and profitability across its global markets. Subscriber numbers grew 10% on an underlying basis to 4.41 million while average revenue per user increased 11%. Xero continues to execute its FY25-27 “Winning on Purpose” strategy focused on its 3x3 growth pillars across Australia, UK and the US.
WiseTech Global Limited (ASX: WTC)
has reported a strong FY25 financial performance with total revenue rising 14% to USD 778.7 million and underlying NPAT increasing 30% to USD 241.8 million. CargoWise revenue grew 18% to USD 682.2 million which was driven by existing and new customers including significant Large Global Freight Forwarder rollouts. EBITDA excluding e2open M&A costs rose 26% to USD 409.5 million with an EBITDA margin of 53%. The company declared a 24% higher final dividend of 7.7 cents per share.
(Source: Company Announcements)
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
